Breaking Business News | Breaking business news AM | Breaking Business News PM

Gilead expects to spend up to $1 billion on coronavirus drug this year, will donate 1.5 million vials

30 Apr 2020

Gilead Sciences Inc. reported better-than-expected earnings for the first quarter of the year on Thursday and detailed more of its work on remdesivir, an antiviral COVID-19 drug candidate.


Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download